ArticleBMC infectious diseases2016

In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.

Yi-Fan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.